Angioimmunoblastic T-cell lymphoma: still a dismal prognosis with current treatment approaches.
Pro
Barbara
B
M.D. Anderson Cancer Center, Lymphoma/Myeloma Department, Houston, Texas 77030, USA. bpro@anderson.org
McLaughlin
Peter
P
D018943:Anthracyclines / Q000494:pharmacology; D018572:Disease-Free Survival; D006801:Humans; D016399:Lymphoma, T-Cell / Q000276:immunology* / Q000628:therapy*; D009389:Neovascularization, Pathologic; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome
D018943:Anthracyclines